LGND insider buying and SEC filings, explained
Ligand Pharmaceuticals Inc. · CIK 886163
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$7.7M
Planned sales (10b5-1)
$24.1M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 30–Nov 2, 2026 | Sale | Jason Aryeh (Director) sold 2,111 shares between Oct 30 and Nov 2 at about $320.30 ($676K). Holdings down 2% to 108,758 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2026, 7:39 PM ET |
| Oct 2, 2026 | Planned (10b5-1) | Andrew Reardon (CLO & Secretary) sold 5,000 shares at about $304.07 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 14% to 31,854 shares. | SEC filing Filed Oct 6, 2026, 4:35 PM ET |
| Sep 10, 2026 | Sale | Martine Zimmermann (Director) sold 1,200 shares at $285.00 ($342K). Holdings down 24% to 3,897 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 14, 2026 |
| Sep 3, 2026 | Planned (10b5-1) | Andrew Reardon (CLO & Secretary) sold 5,000 shares at about $286.09 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 12% to 36,514 shares. | SEC filing Filed Sep 8, 2026 |
| Aug 12, 2026 | Planned (10b5-1) | Octavio Espinoza (CFO) sold 31,641 shares at about $292.07 ($9.2M), marked as a 10b5-1 plan trade. Holdings down 53% to 27,696 shares. | SEC filing Filed Aug 14, 2026 |
| Aug 12, 2026 | Sale | Jason Haas (Director) sold 7,138 shares at about $292.81 ($2.1M). Holdings down 64% to 3,981 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 14, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Andrew Reardon (CLO & Secretary) sold 5,000 shares at about $288.99 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 11% to 41,514 shares. | SEC filing Filed Aug 4, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Andrew Reardon (CLO & Secretary) sold 5,000 shares at about $313.28 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 11% to 41,514 shares. | SEC filing Filed Jul 6, 2026 |
| Jun 12, 2026 | Sale | Jason Haas (Director) sold 6,461 shares at about $255.58 ($1.7M). Holdings down 56% to 4,981 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 10, 2026 | Sale | John L. Lamattina (Director) sold 4,591 shares at about $250.88 ($1.2M). Holdings down 15% to 26,969 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 12, 2026 |
| Jun 10–11, 2026 | Sale | Jason Aryeh (Director) sold 5,000 shares between Jun 10 and Jun 11 at $250.00 ($1.3M). Holdings down 5% to 102,580 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 12, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Andrew Reardon (CLO & Secretary) sold 5,000 shares at about $227.06 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 11% to 41,382 shares. | SEC filing Filed Jun 2, 2026 |
| May 1–13, 2026 | Planned (10b5-1) | John W. Kozarich (Director) sold 2,501 shares between May 1 and May 13 at about $225.14 ($563K), marked as a 10b5-1 plan trade. Holdings down 6% to 41,786 shares. | SEC filing Filed May 14, 2026 |
| May 1, 2026 | Planned (10b5-1) | Andrew Reardon (CLO & Secretary) sold 5,000 shares at about $231.31 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 11% to 41,382 shares. | SEC filing Filed May 4, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | John W. Kozarich (Director) sold 467 shares at about $202.22 ($94K), marked as a 10b5-1 plan trade. Holdings down 1% to 42,253 shares. | SEC filing Filed Apr 2, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Andrew Reardon (CLO & Secretary) sold 5,000 shares at about $201.24 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 11% to 41,382 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 23, 2026 | Sale | Stephen L Sabba (Director) sold 1,000 shares at $207.87 ($208K). Holdings down 3% to 32,793 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 25, 2026 |
| Mar 11, 2026 | Planned (10b5-1) | Octavio Espinoza (CFO) sold 3,057 shares at $225.00 ($688K), marked as a 10b5-1 plan trade. Holdings down 13% to 21,010 shares. | SEC filing Filed Mar 13, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Andrew Reardon (CLO & Secretary) sold 5,000 shares at about $206.35 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 12% to 36,869 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Octavio Espinoza (CFO) sold 13,423 shares at about $205.83 ($2.8M), marked as a 10b5-1 plan trade. Holdings down 38% to 21,662 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | John W. Kozarich (Director) sold 467 shares at about $200.50 ($94K), marked as a 10b5-1 plan trade. Holdings down 1% to 42,720 shares. | SEC filing Filed Mar 4, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | John W. Kozarich (Director) sold 467 shares at about $195.91 ($91K), marked as a 10b5-1 plan trade. Holdings down 1% to 43,187 shares. | SEC filing Filed Feb 4, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | John W. Kozarich (Director) sold 467 shares at about $189.58 ($89K), marked as a 10b5-1 plan trade. Holdings down 1% to 43,654 shares. | SEC filing Filed Jan 6, 2026 |
| Dec 12, 2025 | Sale | Octavio Espinoza (CFO) sold 1,804 shares at $188.31 ($340K). Holdings down 6% to 26,186 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 16, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | John W. Kozarich (Director) sold 467 shares at about $195.84 ($91K), marked as a 10b5-1 plan trade. Holdings down 1% to 44,121 shares. | SEC filing Filed Dec 3, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | John W. Kozarich (Director) sold 467 shares at about $191.05 ($89K), marked as a 10b5-1 plan trade. Holdings down 1% to 44,588 shares. | SEC filing Filed Nov 5, 2025 |
45 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow LGND in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.